HUP0200055A2 - 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények - Google Patents

16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0200055A2
HUP0200055A2 HU0200055A HUP0200055A HUP0200055A2 HU P0200055 A2 HUP0200055 A2 HU P0200055A2 HU 0200055 A HU0200055 A HU 0200055A HU P0200055 A HUP0200055 A HU P0200055A HU P0200055 A2 HUP0200055 A2 HU P0200055A2
Authority
HU
Hungary
Prior art keywords
compounds
hydroxyestrienes
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0200055A
Other languages
English (en)
Inventor
Ulf Bömer
Karl-Heinrich Fritzemeier
Christa Hegele-Hartung
Rudolf Knauthe
Dirk Kosemund
Hermann Künzer
Monika Lessl
Gerd Müller
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of HUP0200055A2 publication Critical patent/HUP0200055A2/hu
Publication of HUP0200055A3 publication Critical patent/HUP0200055A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0055—Estrane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings

Abstract

A találmány tárgyát a következők képezik: (I) általános képletűvegyületek mint gyógyászati hatóanyagok, amelyek hatást fejtenek ki acsontokra és/vagy hatást mutatnak az 5HT2a receptor és transzporter kifejeződésének stimulálására és az új vegyületeket tartalmazó különbözőkikészítésű gyógyászati készítmények. Az (I) általános képletűvegyületek új típusú 16a- és 16b-hidroxi-ösztra-1,3,5/10/-ösztratriének, amelyek a szteroid vázon további helyettesítőkethordoznak és a B, C és/vagy D gyűrűben egy vagy több további kettőskötést tartalmazhatnak. Ó
HU0200055A 1999-02-09 2000-02-09 16-hydroxyestrienes and pharmaceutical compositions containing the same HUP0200055A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906159A DE19906159A1 (de) 1999-02-09 1999-02-09 16-Hydroxyestratriene als selektiv wirksame Estrogene

Publications (2)

Publication Number Publication Date
HUP0200055A2 true HUP0200055A2 (hu) 2002-05-29
HUP0200055A3 HUP0200055A3 (en) 2002-10-28

Family

ID=7897485

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200055A HUP0200055A3 (en) 1999-02-09 2000-02-09 16-hydroxyestrienes and pharmaceutical compositions containing the same

Country Status (30)

Country Link
EP (2) EP1144431B1 (hu)
JP (1) JP2002536455A (hu)
KR (1) KR20010101822A (hu)
CN (1) CN1346364A (hu)
AR (1) AR034392A1 (hu)
AT (1) ATE313553T1 (hu)
AU (1) AU2909500A (hu)
BG (1) BG105804A (hu)
BR (1) BR0008076A (hu)
CA (1) CA2359660A1 (hu)
CO (1) CO5150223A1 (hu)
CZ (1) CZ20012843A3 (hu)
DE (2) DE19906159A1 (hu)
DK (1) DK1144431T3 (hu)
EA (1) EA200100828A1 (hu)
EE (1) EE200100412A (hu)
ES (1) ES2255983T3 (hu)
HK (1) HK1046145A1 (hu)
HU (1) HUP0200055A3 (hu)
IL (1) IL144455A0 (hu)
MX (1) MXPA01008065A (hu)
NO (1) NO20013860L (hu)
NZ (1) NZ513409A (hu)
PE (1) PE20001461A1 (hu)
PL (1) PL350360A1 (hu)
PT (1) PT1144431E (hu)
SK (1) SK11302001A3 (hu)
WO (1) WO2000047603A2 (hu)
YU (1) YU57201A (hu)
ZA (1) ZA200107388B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10039199A1 (de) * 2000-08-10 2002-02-21 Schering Ag Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen
DE10048634A1 (de) * 2000-09-27 2002-04-18 Jenapharm Gmbh 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21, 16alpha-Laktonring
DE10151365A1 (de) 2001-10-17 2003-04-30 Schering Ag 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten
DK1365768T3 (da) * 2001-02-27 2008-08-18 Bayer Schering Pharma Ag Anvendelse af ER-beta-selektive antagonister som contraception.
DE10151114A1 (de) * 2001-10-15 2003-04-17 Schering Ag 8ß-Substituierte-11ß-aryl-estra-2,3,5(10)-trienderivate
DE10151363A1 (de) * 2001-10-17 2003-05-08 Schering Ag Somatotrope Therapie
DE10226326A1 (de) * 2002-06-11 2004-01-15 Schering Ag 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene
US7414043B2 (en) 2002-06-11 2008-08-19 Schering Ag 9-α-substituted estratrienes as selectively active estrogens
TWI392682B (zh) * 2006-04-13 2013-04-11 Sigma Tau Ind Farmaceuti 作為心血管疾病的治療藥物之雄甾烷和雄甾烯的胺基衍生物
TWI389917B (zh) * 2006-04-13 2013-03-21 Sigma Tau Ind Farmaceuti 作為心血管疾病治療藥物的雄甾烷與雄甾烯之氮雜環烷基衍生物
SE536263C2 (sv) * 2011-12-21 2013-07-23 Airqone Building Scandinavia Ab Reningsanordning för gasmedium innefattande medel för kontrollerad tillförsel av joniserad luft
PL3500265T3 (pl) * 2016-08-22 2024-03-11 Or-Genix Therapeutics, Inc. Selektywne ligandy receptora estrogenowego beta
WO2019041078A1 (en) * 2017-08-28 2019-03-07 Zhejiang Jiachi Pharmaceutical Development Ltd. ASYMMETRIC SYNTHESIS AND USES OF COMPOUNDS IN TREATMENT OF DISEASES
JP2021535183A (ja) * 2018-09-07 2021-12-16 トラスティーズ・オヴ・ダートマス・カレッジ Ｃ１９骨格およびステロイドならびにそれらの使用および製造方法
CN115154474A (zh) * 2021-04-01 2022-10-11 中国人民解放军总医院 一种环菠萝蜜烷型三萜皂苷化合物在制备t细胞免疫抑制剂中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3079408A (en) * 1963-02-26 Ig-bisoxygenated iy-haloestra-
US3103524A (en) * 1963-09-10 Ratetraene-
GB823955A (en) * 1955-09-01 1959-11-18 Nepera Chemical Co Inc Improvements in steroid compounds and method for manufacture of same
GB804789A (en) * 1956-02-06 1958-11-26 Searle & Co 16-alkylestratriene-3,16,17-triols and derivatives thereof
US2779773A (en) * 1956-05-23 1957-01-29 Nepera Chemical Co Inc Steroid 3, 16alpha-diols and process
US3166473A (en) * 1962-04-12 1965-01-19 Mochida Pharm Co Ltd New esters of 1, 3, 5-estratriene-3, 16, 17-triol and novel pharmaceutical compositions containing new esters of 1, 3, 5-estratriene-3, 16, 17-triol and esters of 1, 3, 5-estratriene-3, 16, 17-triol
NL124324C (hu) * 1964-01-24
FR4339M (hu) * 1965-03-29 1966-08-08
FR5099M (hu) * 1966-01-12 1967-05-22
US3449383A (en) * 1967-02-16 1969-06-10 Searle & Co 17-oxygenated estra-1,3,5(10)-triene-3,11beta,16-triols,ethers and esters thereof
US3470159A (en) * 1967-07-13 1969-09-30 American Home Prod Estra-1,3,5(10),7-tetraenes and process of preparation
CH538460A (de) * 1969-02-27 1973-06-30 Ciba Geigy Ag Verfahren zur Herstellung eines neuen hochwirksamen Östratriols
FR2034569B1 (hu) * 1969-02-27 1973-07-13 Ciba Geigy Ag
GB1235642A (en) * 1969-02-27 1971-06-16 Ciba Geigy A new oestratriol and a process for its manufacture
CH537915A (de) * 1969-02-27 1973-06-15 Ciba Geigy Ag Verfahren zur Herstellung eines neuen Östratriols
US3600705A (en) * 1969-02-27 1971-08-17 Gen Electric Highly efficient subcritically doped electron-transfer effect devices
US3622670A (en) * 1969-08-22 1971-11-23 American Home Prod Method of inducing ovulation
IL38806A0 (en) * 1971-03-05 1972-04-27 Ciba Geigy Ag Pharmaceutical compositions comprising estrogens and anthracene derivatives
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
US3946052A (en) * 1975-06-16 1976-03-23 Stanford Research Institute 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity
JPS5265259A (en) * 1975-11-27 1977-05-30 Takeda Chem Ind Ltd Synthesis of 16beta-alkylestradiol or its 17-esters
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
DD145919B1 (de) * 1978-06-28 1982-06-30 Kurt Ponsold Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe
SE8305596D0 (sv) * 1983-10-12 1983-10-12 Leo Ab A selective acylation method
DE3510555A1 (de) * 1985-03-21 1986-09-25 Schering AG, 1000 Berlin und 4709 Bergkamen Estriolester
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes
HU208150B (en) * 1988-10-31 1993-08-30 Endorecherche Inc Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives
SU1761760A1 (ru) * 1990-07-02 1992-09-15 Всесоюзный Эндокринологический Научный Центр Амн Ссср Способ получени 11-нитратов 9 @ , 11 @ -диоксистероидов
DE4239946C2 (de) * 1992-11-27 2001-09-13 Jenapharm Gmbh Estranderivate mit einer 14alpha,15alpha-Methylengruppe und Verfahren zu ihrer Herstellung
DE4322186A1 (de) * 1993-07-03 1995-01-12 Jenapharm Gmbh Oral estrogen wirksame Ester des 14alpha, 15alpha-Methylen-estradiols
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
US5554603A (en) * 1993-09-17 1996-09-10 The United States Of America As Represented By The Department Of Health And Human Services Orally active derivatives of 1,3,5(10)-estratriene
DE4338314C1 (de) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen
SE9502921D0 (sv) * 1995-08-23 1995-08-23 Astra Ab New compounds
DE19635525A1 (de) * 1996-08-20 1998-02-26 Schering Ag 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19815060A1 (de) * 1998-04-03 1999-10-14 Jenapharm Gmbh Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie

Also Published As

Publication number Publication date
NZ513409A (en) 2004-02-27
AU2909500A (en) 2000-08-29
ES2255983T3 (es) 2006-07-16
CZ20012843A3 (cs) 2002-01-16
WO2000047603A9 (de) 2001-09-07
ZA200107388B (en) 2005-01-25
KR20010101822A (ko) 2001-11-14
PL350360A1 (en) 2002-12-02
EE200100412A (et) 2002-12-16
NO20013860D0 (no) 2001-08-08
PT1144431E (pt) 2006-05-31
HK1046145A1 (zh) 2002-12-27
YU57201A (sh) 2005-06-10
PE20001461A1 (es) 2000-12-18
CN1346364A (zh) 2002-04-24
WO2000047603A2 (de) 2000-08-17
JP2002536455A (ja) 2002-10-29
NO20013860L (no) 2001-10-08
DE19906159A1 (de) 2000-08-10
WO2000047603A3 (de) 2001-08-02
IL144455A0 (en) 2002-05-23
DK1144431T3 (da) 2006-05-08
HUP0200055A3 (en) 2002-10-28
EP1144431A2 (de) 2001-10-17
EP1144431A3 (de) 2002-06-12
SK11302001A3 (sk) 2002-01-07
EA200100828A1 (ru) 2002-04-25
ATE313553T1 (de) 2006-01-15
AR034392A1 (es) 2004-02-25
BR0008076A (pt) 2002-02-05
CO5150223A1 (es) 2002-04-29
EP1144431B1 (de) 2005-12-21
EP1580192A2 (de) 2005-09-28
CA2359660A1 (en) 2000-08-17
BG105804A (en) 2002-03-29
MXPA01008065A (es) 2002-04-24
DE50011908D1 (de) 2006-01-26

Similar Documents

Publication Publication Date Title
HUP0200055A2 (hu) 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények
ATE429210T1 (de) Orale flüssige zusammensetzungen
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
HUP0300836A2 (hu) Taxánokat tartalmazó szájon át beadható gyógyszerkészítmények és ezek alkalmazása
DE69620877T2 (de) Arzneimittelformulierungen für il-12
DE69725608D1 (de) Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
IS6658A (is) Ný efnasambönd
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
SE9904505D0 (sv) Novel compounds
NO20062824L (no) 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme
ATE231872T1 (de) Thiazolopyrimidinderivate
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
IS8051A (is) Kladríbínefnablöndur til inngjafar um munn
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
DE60001586D1 (de) Diphenyl-piperidin derivate
HUP0301713A2 (hu) Propenonszármazékokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
ID21353A (id) Senyawa bi-aromatik yang terikat melalui radikal heteroetilena, serta komposisi farmasi dan kosmetik yang mengandungnya
AP2001002369A0 (en) Pharmaceutical complex.
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение